Search results for "Infarction"

showing 10 items of 1208 documents

Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction

2015

– Transient hypokinesis, akinesis, or dyskinesis of the left ventricular mid-segments with or without apical involvement; the regional wall motion abnormalities extend beyond a single epicardial vascular distribution; a stressful trigger is often, but not always, present; – Absence of obstructive coronary disease or angiographic evidence of acute plaque rupture; – New ECG abnormalities (either ST-segment elevation and/or T wave inversion) or modest elevation in cardiac troponin; and – Absence of pheochromocytoma or myocarditis.

Malemedicine.medical_specialtyLeft ventricular ejection fractionMyocarditisCardiomyopathyMyocardial InfarctionAcute myocardial infarctionPheochromocytomaDiagnosis DifferentialElectrocardiographyTakotsubo CardiomyopathyT waveInternal medicineTroponin ImedicineHumansMyocardial infarctionAgedEjection fractionbiologybusiness.industryMedicine (all)Troponin IStroke VolumeMiddle Agedmedicine.diseaseTroponinSettore MED/11 - Malattie Dell'Apparato CardiovascolareTroponinbiology.proteinCardiologyFemalebusinessCardiology and Cardiovascular MedicineHuman
researchProduct

Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of cardiac comorbidity on surgical outcome.

2013

Principles The aim of this study was to evaluate the impact of cardiac comorbidity on the perioperative morbidity and mortality after lobar lung resection for lung cancer in patients aged 70 years and older. Methods The medical records of all 68 patients ≥70 years, who underwent lobar lung resection for non-small cell lung cancer (NSCLC) from 2003 to 2011 at our department, were reviewed retrospectively. Twenty-two patients with a mean age of 76.3 years had cardiac comorbidities (Group A) including previous cardiac operations in 4 patients, previous myocardial infarction in 5 patients, previous coronary stent insertion in 3 patients, medically treated coronary artery disease in 10 patients …

Malemedicine.medical_specialtyLung NeoplasmsHeart Diseasesmedicine.medical_treatmentComorbidityCoronary artery diseaseCarcinoma Non-Small-Cell LungCoronary stentMedicineHumansMyocardial infarctionLung cancerPneumonectomyAgedRetrospective StudiesAged 80 and overbusiness.industryvalvular heart diseaseAge FactorsRetrospective cohort studyGeneral MedicinePerioperativemedicine.diseaseComorbiditySurgeryFemalebusinessSwiss medical weekly
researchProduct

Tobacco-related cardiovascular risk in women: New issues and therapeutic perspectives

2021

Smoking is the main modifiable risk factor for stroke and myocardial infarction, particularly in women; its prevalence in France is evolving, and new patterns of nicotine consumption have emerged.To present contemporary data on smoking prevalence and the use of electronic cigarettes, and to describe current knowledge of the cardiovascular risk specificities and the effectiveness of withdrawal methods in women.We identified studies by searching the MEDLINE bibliographic database between 1995 and 2020, and the Weekly Epidemiological Bulletin (Bulletin Épidémiologique Hebdomadaire) published by the French health authorities.In recent years, smoking prevalence among French women has decreased o…

Malemedicine.medical_specialtyMEDLINEElectronic Nicotine Delivery Systemslaw.inventionNicotineRisk FactorslawEnvironmental healthTobaccoEpidemiologymedicineHumansMyocardial infarctionRisk factorStrokebusiness.industryIncidence (epidemiology)Tobacco ProductsGeneral MedicineMiddle Agedmedicine.diseaseTobacco Use Cessation DevicesCardiovascular DiseasesHeart Disease Risk FactorsFemaleSmoking CessationCardiology and Cardiovascular MedicinebusinessElectronic cigarettemedicine.drugArchives of Cardiovascular Diseases
researchProduct

Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.

2022

BACKGROUND: Cardiac magnetic resonance (CMR) performed early after ST-segment elevation myocardial infarction (STEMI) can improve major adverse cardiac event (MACE) risk prediction. We aimed to create a simple clinical-CMR risk score for early MACE risk stratification in STEMI patients.; METHODS: We performed a multicenter prospective registry of reperfused STEMI patients (n=1118) in whom early (1-week) CMR-derived left ventricular ejection fraction (LVEF), infarct size and microvascular obstruction (MVO) were quantified. MACE was defined as a combined clinical endpoint of cardiovascular (CV) death, non-fatal myocardial infarction (NF-MI) or re-admission for acute decompensated heart failur…

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyAcute decompensated heart failureMyocardial InfarctionMagnetic Resonance Imaging CineVentricular Function LeftPercutaneous Coronary InterventionRisk FactorsInternal medicineClinical endpointMedicineHumansMyocardial infarctioncardiovascular diseasesAgedFramingham Risk ScoreEjection fractionbusiness.industryMean ageStroke VolumeMiddle Agedmedicine.diseasePrognosiscardiovascular systemCardiologyST Elevation Myocardial InfarctionCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceMace
researchProduct

Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance.

2016

Cardiovascular magnetic resonance (CMR) predicts combined clinical events in post-ST-segment elevation myocardial infarction (STEMI) patients. However, its contribution to predicting long-term major events (ME: cardiac death and non-fatal myocardial infarction [MI]) is unknown. We aimed to assess whether CMR predicts long-term MEs when performed soon after STEMI.We prospectively recruited 546 STEMI patients between 2004 and 2012. The Left ventricular (LV) ejection fraction (LVEF,%), infarct size (IS), edema, hemorrhage, microvascular obstruction, and myocardial salvage were quantified by CMR at pre-discharge. During a mean follow-up of 840 days, 57 ME events (10%; 23 cardiac deaths, 34 non-…

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyMyocardial InfarctionHemorrhage030204 cardiovascular system & hematologyTime03 medical and health sciencesVentricular Dysfunction Left0302 clinical medicineEdemaInternal medicinemedicineST segmentEdemaHumansRadiology Nuclear Medicine and imagingcardiovascular diseases030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesEjection fractionmedicine.diagnostic_testClinical eventsbusiness.industryMyocardiumReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle AgedInfarct sizemedicine.diseaseMicrovesselscardiovascular systemCardiologyFemalemedicine.symptombusinessCardiac deathsFollow-Up StudiesEuropean journal of radiology
researchProduct

EpCAM and microvascular obstruction in patients with STEMI: a cardiac magnetic resonance study

2020

Abstract Introduction and objectives Microvascular obstruction (MVO) is negatively associated with cardiac structure and worse prognosis after ST-segment elevation myocardial infarction (STEMI). Epithelial cell adhesion molecule (EpCAM), involved in epithelium adhesion, is an understudied area in the MVO setting. We aimed to determine whether EpCAM is associated with the appearance of cardiac magnetic resonance (CMR)-derived MVO and long-term systolic function in reperfused STEMI. Methods We prospectively included 106 patients with a first STEMI treated with percutaneous coronary intervention, quantifying serum levels of EpCAM 24 hours postreperfusion. All patients underwent CMR imaging 1 w…

Malemedicine.medical_specialtyMagnetic Resonance Spectroscopymedicine.medical_treatmentMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyVentricular Function Left03 medical and health scienceschemistry.chemical_compoundPercutaneous Coronary Intervention0302 clinical medicineInternal medicinemedicineHumansIn patientcardiovascular diseasesMyocardial infarctionVentricular remodelingEnd-systolic volumeAgedEjection fractionbusiness.industryMicrocirculationPercutaneous coronary interventionStroke VolumeEpithelial cell adhesion moleculeGeneral MedicineMiddle AgedEpithelial Cell Adhesion Moleculemedicine.diseaseMagnetic Resonance ImagingchemistryCardiologyST Elevation Myocardial InfarctionFemalebusinessCardiac magnetic resonancehuman activitiesRevista Española de Cardiología (English Edition)
researchProduct

Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart.

1991

The glutathione redox pathway is an important antioxidant system in the myocardium. N-Acetylcysteine is a low molecular weight glutathione precursor that has been used clinically to replenish glutathione stores. The present study was aimed at evaluating the protective effect of N-acetylcysteine on myocardial damage resulting from permanent coronary occlusion (without reperfusion) in anaesthetized dogs. N-Acetylcysteine (150 mg kg−1 i.v.) administered 2 min before occlusion rerduced infarct size in dogs subjected to 24 h ischemia. The infarct size as a percentage of the area at risk was 86.8 ± 3.6% (n = 11) in control (salinetreated) dogs and 68.2 ± 2.4% (n = 7; P < 0.05 vs control) in N-ace…

Malemedicine.medical_specialtyMean arterial pressureTime FactorsIschemiaMyocardial InfarctionHemodynamicsCoronary DiseaseAcetylcysteinechemistry.chemical_compoundDogsInternal medicineCoronary CirculationmedicineAnimalsMyocardial infarctionPharmacologybusiness.industryGeneral MedicineGlutathionemedicine.diseaseMalondialdehydeGlutathioneAcetylcysteineDisease Models AnimalchemistryCoronary occlusionAnesthesiaCardiologyFemalebusinessmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Administration of transforming growth factor-α reduces infarct volume after transient focal cerebral ischemia in the rat

2001

Growth factors promote cell growth and survival and protect the brain from developing injury after ischemia. In this article, the authors examined whether transforming growth factor-α (TGF-α was protective in transient focal ischemia and whether alteration of cerebral circulation was involved. Rats received intraventricular TGF-α (50 ng, either split into 2 doses given 30 minutes before and 30 minutes after middle cerebral artery occlusion (MCAO), or 1 dose given 30 minutes after MCAO) or vehicle. Rats were subjected to 1-hour intraluminal MCAO and cerebral blood flow was recorded continuously by laser-Doppler flowmetry. Infarct volume was measured 1 and 4 days later. The effects of TGF-α o…

Malemedicine.medical_specialtyMicrovascular perfusionCerebral arteriesIschemiaRabbitIn Vitro Techniques030218 nuclear medicine & medical imagingMicrocirculationBrain IschemiaRats Sprague-Dawley03 medical and health sciencesCerebral circulation0302 clinical medicineInternal medicinemedicineAnimalscardiovascular diseasesMiddle cerebral artery occlusionCerebral infarctionbusiness.industryMicrocirculationInfarction Middle Cerebral ArteryTransforming Growth Factor alphamedicine.diseaseRatsCarotid ArteriesNeuroprotective AgentsNeurologyCerebral blood flowVasoconstrictionAnesthesiaBasilar ArteryCerebrovascular CirculationCardiologyRatNeurology (clinical)Rabbitsmedicine.symptomCardiology and Cardiovascular MedicinebusinessGrowth factors030217 neurology & neurosurgeryVasoconstrictionTransforming growth factor
researchProduct

Diabetic 3rd nerve palsy: evidence for a mesencephalic lesion.

1990

Eleven consecutive adult chronic diabetic patients presented with an isolated 3rd nerve palsy (8 with pupillary sparing) of which 10 had abnormal ipsilateral or bilateral masseter reflexes (MassR). Three patients had an MRI lesion in the ipsilateral oculomotor fasciculus and 3 had subsequent mild brainstem signs. An additional 13 patients with Weber's syndrome had similar ipsilateral or bilateral MassR abnormalities, while 7 patients with 3rd nerve palsies on a known extra-axial basis had none. The findings suggest that an isolated diabetic 3rd nerve palsy, with or without pupillary sparing, is much more likely on the basis of a focal mesencephalic infarct than a peripheral nerve lesion.

Malemedicine.medical_specialtyMidbrainMasseter muscleLesionDiabetic NeuropathiesOculomotor NerveMesencephalonDiabetes mellitusFasciculusParalysisOculomotor Nerve DiseasesMedicineHumansAgedAged 80 and overbiologybusiness.industryCerebral InfarctionMiddle Agedbiology.organism_classificationmedicine.diseaseSurgeryAnesthesiaReflexFemaleNeurology (clinical)Brainstemmedicine.symptombusinessNeurology
researchProduct

Positional brain ischemia with MCA occlusion successfully treated with extra-intracranial bypass.

2010

408 Positional cerebral ischemia (PCI) is an extremely rare condition in which dramatic central nervous system deficits are triggered by standing in patients with severe stenosis or occlusion of the major brain-supplying blood vessels [1] . Because PCI is generally associated with orthostatic hypotension [2, 3] , a hemodynamic mechanism has been proposed [4] . However, PCI has been reported even in patients without orthostatic hypotension [1] . The treatment is medical, but surgery can be considered in refractory cases (endarterectomy for carotid artery stenosis or either highor low-flow extra-intracranial bypass – for carotid occlusion) [3] . We report a case of PCI associated with middle …

Malemedicine.medical_specialtyMiddle Cerebral ArterySettore MED/09 - Medicina InternaTiclopidinePostureIschemiaHemodynamicsOrthostatic vital signsmedicine.arteryInternal medicineParietal LobeOcclusionmedicineHumansThrombophiliacardiovascular diseasesCerebral perfusion pressureTomography Emission-Computed Single-Photonpositional ischemia Extracranial by-passAspirinCerebral Revascularizationbusiness.industryInfarction Middle Cerebral ArteryMiddle Agedmedicine.diseaseMagnetic Resonance ImagingClopidogrelTemporal ArteriesParesisHemiparesisBlood pressureNeurologyIschemic Attack TransientAnesthesiaMiddle cerebral arteryCardiologyNeurology (clinical)medicine.symptomCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsCerebrovascular diseases (Basel, Switzerland)
researchProduct